#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma Anti-HLA antibody test positive Niemann-Pick disease Retinoblastoma Complex regional pain syndrome Fallopian tube cancer Follicular lymphoma stage I Drug eruption Primary mediastinal large B-cell lymphoma Adenovirus infection Familial haemophagocytic lymphohistiocytosis Marginal zone lymphoma Non-Hodgkin's lymphoma refractory Osteosarcoma recurrent Anal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis – Diagnostics Phenylketonuria – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Pituitary-dependent Cushing’s syndrome – Trials in Disease Metachromatic leukodystrophy – Treatment Marginal zone lymphoma refractory – Diagnostics Primary hyperoxaluria – Trials in Disease Alport’s syndrome Loeys-Dietz syndrome – Basic Information Undifferentiated sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    DAPIGLUTIDE Sodium Butyrate Ds-2325A Dotatate ACETYLCARNITINE HYDROCHLORIDE Enfortumab Vedotin Lisinopril Dihydrate Ddcart‐Cd19 Bedaquiline Urapidil Inaxaplin Fenofibrate Tebentafusp Anselamimab Vindesine Sulfate Somapacitan Secale Cereale Vutrisiran Ipilimumab Rucaparib More therapies…

    Learn about Your Condition

    Herpes simplex reactivation Status epilepticus Small cell lung cancer Non-Hodgkin's lymphoma Cold urticaria Cholangitis sclerosing Krabbe's disease Genital herpes Skin disorder Vertebrobasilar stroke Interstitial lung disease Pigmentary glaucoma Neuropathic arthropathy Fallopian tube cancer Cutibacterium acnes infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac amyloidosis

  • Evaluation of [68Ga]Ga-FAPI-46 PET Imaging for Staging and Detecting Disease Progression in Patients with Transthyretin Cardiac Amyloidosis

    Recruiting

    2 1 1
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • A Study of Acoramidis in Adult Patients with Transthyretin Amyloidosis with Cardiomyopathy Who Previously Received Tafamidis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acoramidis
    Austria Belgium Germany Italy

  • Study to Diagnose Cardiac Amyloidosis in Patients with Monoclonal Component Using Florbetaben (18F) PET-CT

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Florbetaben (18F)
    Italy

  • Long-Term Safety Study of NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy or Transthyretin Amyloidosis-Related Cardiomyopathy

    Recruiting

    4 1 1
    Investigated Drugs:
    • Single Guide Rna Targeting The Human Ttr Gene
    • Ziclumeran
    France Sweden

  • Study on the Effects of Dobutamine on Heart Function in Patients with Wild-type Transthyretin Amyloid Cardiomyopathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Dobutamine
    • Sodium Chloride
    Denmark

  • Study on the Impact of Dapagliflozin on Quality of Life and Exercise Capacity in Patients with Transthyretin Cardiac Amyloidosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    • Acquired ATTR amyloidosis
    Investigated Drugs:
    • Dapagliflozin
    Italy
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!